IMRIS Inc. and Siemens Healthcare announced an agreement that positions one of Siemens’s computed tomography (CT) products as the core of the IMRIS Visius iCT solution.

At RSNA 2013, ContextVision will announce its latest additions to its U.S. PlusView Family, which will include four different packages for women’s health, general imaging, cardiovascular and point of care (POC). More anatomically correct images provide medical professionals diagnostic confidence for the most complex patient cases. 

The U.S. Food and Drug Administration's (FDA) Circulatory Systems Devices Advisory Panel this week voted that biventricular (BiV) pacing with Medtronic Inc. devices is beneficial for treating patients who have atrioventricular (AV) block and left ventricular (LV) systolic dysfunction, compared to conventional right ventricular pacing. 

Terumo Interventional Systems, a division of Terumo Medical Corp., announced the nationwide availability of the Azur CX Peripheral Coil System (Azur CX), the first and only peripheral embolization coil designed to provide cross-sectional coverage incorporating the benefits of Terumo's hydrogel technology.

cardiac stem cell regeneration therapy translational medicine louisville study

A study in Stem Cells Translational Medicine shows that in rats, treating a heart attack with stem cells even weeks after the attack occurred can halt deterioration and help the heart regenerate itself. In addition, doctors delivered the cells using a patch that resulted in a higher survival rate for the stem cells and more of them migrating into the damaged tissue, where they created new blood vessels.

Micell Technologies Inc. announced that a peer reviewed article discussing imaging and clinical results of the Dessolve I trial of its MiStent Sirolimus Eluting Absorbable Polymer Coronary Stent System (MiStent SES) was accepted for publication on the JACC Cardiovascular Interventions website. The paper, "First-in-Human Evaluation of a Bioabsorbable Polymer–Coated Sirolimus-Eluting Stent: Imaging and Clinical Results of the Dessolve I Trial (DES With Sirolimus and a Bioabsorbable Polymer for the Treatment of Patients With De Novo Lesion in the Native Coronary Arteries)", is planned to also appear in the October 2013 issue of JACC Cardiovascular Interventions.

Biotronik announced it has completed patient enrollment in the iliac arm of its Bioflex-I trial. Under the supervision of Mark Burket, M.D. and chief, Cardiovascular Division at the University of Toledo Medical Center, the trial will evaluate the safety and effectiveness of the Astron and Pulsar-18 stents in the treatment of peripheral vascular disease with a view towards gaining U.S. Food and Drug Administration (FDA) approval.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now